OTP Exclusive Interview: OFA Legal Counsel Talks Future of Compound Tirzepatide
In an exclusive On The Pen interview, Andrew Grossman, legal counsel for the Outsourcing Facilities Association (OFA), offered one reassurin
OTP Exclusive Interview: OFA Legal Counsel Talks Future of Compound Tirzepatide
Leptin and GLP-1: The Next (old) Frontier in Obesity Treatment?
Telehealth and Obesity Care: New Data Shows the Power of Combining GLP-1 Medications with Virtual Platforms
Obesity is a complex, chronic disease that the American Medical Association recognized in 2013. Like any illness, it deserves effective medical treatment and support. Our FAQ page can help you get started, from talking to your doctor about medications like Zepbound and Wegovy to navigating insurance challenges.